Modulation of Phospholipid Bilayer Properties by Simvastatin.

Area of Science:

• Biophysics
• Pharmacology
• Computational Chemistry

Background:

• Simvastatin, a cholesterol-lowering drug, exists in inactive lactone and active dihydroxyheptanoate forms.
• Statin-associated myopathy (SAM) and kidney failure are potential side effects linked to lipophilic statins.
• The exact cause of SAM is unknown, but it may involve statin interactions with cell membranes.

Purpose of the Study:

• To investigate the molecular mechanisms of simvastatin's interaction with lipid bilayers.
• To understand how simvastatin's different forms affect membrane properties.
• To explore the role of membrane localization in simvastatin's side effects.

Main Methods:

• All-atom molecular dynamics simulations were performed.
• Simulations used pure POPC and POPC/cholesterol lipid bilayers.
• Potential mean force and electron density profiles were calculated.

Main Results:

• Both simvastatin forms (lactone SN and active SA) spontaneously inserted into lipid bilayers.
• SN localized deeper in the hydrophobic core, while SA formed more hydrogen bonds.
• Simvastatin altered membrane order and fluidity depending on bilayer composition.

Conclusions:

• Simvastatin's interaction with lipid bilayers is form-dependent.
• Membrane properties are modulated by simvastatin, potentially influencing its side effects.
• Further research is needed to fully elucidate the link between simvastatin's membrane interactions and its clinical effects.